TY - CHAP
T1 - Other rare ovarian cancers
T2 - Transitional cell carcinoma, malignant Brenner tumor, endometrioid carcinoma, mesothelioma, squamous cell carcinoma, sarcoma
AU - Somasegar, Sahana
AU - Kertowidjojo, Elizabeth
AU - Chui, M. Herman
AU - Ramalingam, Preetha
AU - Liu, Ying
AU - Aviki, Emeline
N1 - Publisher Copyright:
© 2023 Elsevier Inc. All rights reserved.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - This chapter reviews the epidemiology, clinical presentation, diagnosis, pathology, treatment, surveillance guidelines, and treatment for recurrences for ultrarare ovarian malignancies based on the existing literature and by drawing from similar histologic subtypes from other primary tumor sites. Ovarian cancers are typically classified as epithelial cancers, which comprise 90% to 95% of all ovarian cancer cases, and nonepithelial cancers. Furthermore, among the nonepithelial cancers, there are a group of ultrarare subtypes, which include transitional cell carcinoma, endometrioid carcinoma, neuroendocrine tumors, mesothelioma, squamous cell carcinoma, and ovarian sarcomas. Scarce data exist on the diagnosis, treatment, management, surveillance, and recurrence treatment for these ultrarare subtypes of nonepithelial ovarian cancer, as most information comes from small case reports or case series. While there are some guidelines for management of these tumors, most of the current practice recommendations are extrapolated from guidelines for more common cancers with similar histology.
AB - This chapter reviews the epidemiology, clinical presentation, diagnosis, pathology, treatment, surveillance guidelines, and treatment for recurrences for ultrarare ovarian malignancies based on the existing literature and by drawing from similar histologic subtypes from other primary tumor sites. Ovarian cancers are typically classified as epithelial cancers, which comprise 90% to 95% of all ovarian cancer cases, and nonepithelial cancers. Furthermore, among the nonepithelial cancers, there are a group of ultrarare subtypes, which include transitional cell carcinoma, endometrioid carcinoma, neuroendocrine tumors, mesothelioma, squamous cell carcinoma, and ovarian sarcomas. Scarce data exist on the diagnosis, treatment, management, surveillance, and recurrence treatment for these ultrarare subtypes of nonepithelial ovarian cancer, as most information comes from small case reports or case series. While there are some guidelines for management of these tumors, most of the current practice recommendations are extrapolated from guidelines for more common cancers with similar histology.
KW - Diagnosis
KW - Endometrioid
KW - Mesothelioma
KW - Neuroendocrine
KW - Ovarian cancer
KW - Rare
KW - Sarcoma
KW - Squamous cell
KW - Transitional cell
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85152348976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152348976&partnerID=8YFLogxK
U2 - 10.1016/B978-0-323-82938-0.00008-2
DO - 10.1016/B978-0-323-82938-0.00008-2
M3 - Chapter
AN - SCOPUS:85152348976
SN - 9780323829397
SP - 121
EP - 141
BT - Diagnosis and Treatment of Rare Gynecologic Cancers
PB - Elsevier
ER -